These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 3039340)

  • 41. Compartmentation of receptors and guanine nucleotide-binding proteins in NG108-15 cells: lack of cross-talk in agonist binding among the alpha 2-adrenergic, muscarinic, and opiate receptors.
    Graeser D; Neubig RR
    Mol Pharmacol; 1993 Mar; 43(3):434-43. PubMed ID: 8095695
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Action of alpha 2A-adrenergic receptors in circular smooth muscle of canine proximal colon.
    Zhang L; Keef KD; Bradley ME; Buxton IL
    Am J Physiol; 1992 Mar; 262(3 Pt 1):G517-24. PubMed ID: 1312795
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New tools for human fat cell alpha-2A adrenoceptor characterization. Identification on membranes and on intact cells using the new antagonist [3H]RX821002.
    Galitzky J; Larrouy D; Berlan M; Lafontan M
    J Pharmacol Exp Ther; 1990 Jan; 252(1):312-9. PubMed ID: 1967647
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of temperature and membrane phase transitions on ligand binding to alpha 2-receptors of human platelets.
    Lohse MJ; Klotz KN; Schwabe U
    Mol Pharmacol; 1986 Mar; 29(3):228-34. PubMed ID: 3005830
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Agonist binding at alpha 2-adrenoceptors of human platelets using 3H-UK-14,304: regulation by Gpp(NH)p and cations.
    Schloos J; Wellstein A; Palm D
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):48-59. PubMed ID: 2888026
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alpha 2-adrenergic receptors on canine platelet membranes characterized by [3H]-yohimbine binding.
    O'Hara N; Yokota S; Kouchi Y; Ono H
    Res Commun Chem Pathol Pharmacol; 1986 May; 52(2):179-94. PubMed ID: 3012728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of the human platelet alpha-adrenergic receptor. Correlation of [3H]dihydroergocryptine binding with aggregation and adenylate cyclase inhibition.
    Alexander RW; Cooper B; Handin RI
    J Clin Invest; 1978 May; 61(5):1136-44. PubMed ID: 207726
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modification of receptor-mediated inhibition of adenylate cyclase in NG108-15 neuroblastoma X glioma cells by n-ethylmaleimide.
    Smith MM; Harden TK
    J Pharmacol Exp Ther; 1984 Feb; 228(2):425-33. PubMed ID: 6319678
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of alpha 2-adrenergic receptors in human platelets by binding of a radioactive ligand [3H]yohimbine.
    Mukherjee A
    Biochim Biophys Acta; 1981 Aug; 676(2):148-54. PubMed ID: 6114754
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Precoupling of alpha-2B adrenergic receptors and G-proteins in transfected PC-12 cell membranes: influence of pertussis toxin and a lysine-directed cross-linker.
    Shi AG; Deth RC
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1520-7. PubMed ID: 7996466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alpha-2 adrenoceptors in medullary thick ascending limbs of the rabbit kidney.
    Mohuczy-Dominiak D; Garg LC
    J Pharmacol Exp Ther; 1993 Jul; 266(1):279-87. PubMed ID: 8392554
    [TBL] [Abstract][Full Text] [Related]  

  • 52. p-[125I]iodoclonidine, a novel radiolabeled agonist for studying central alpha 2-adrenergic receptors.
    Baron BM; Siegel BW
    Mol Pharmacol; 1990 Sep; 38(3):348-56. PubMed ID: 1976227
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Binding of [3H]-p-aminoclonidine to alpha 2-adrenoceptor states plus a non-adrenergic site on human platelet plasma membranes.
    Piletz JE; Andorn AC; Unnerstall JR; Halaris A
    Biochem Pharmacol; 1991 Jul; 42(3):569-84. PubMed ID: 1677571
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of adenosine receptors in human erythroleukemia cells and platelets: further evidence for heterogeneity of adenosine A2 receptor subtypes.
    Feoktistov I; Biaggioni I
    Mol Pharmacol; 1993 Jun; 43(6):909-14. PubMed ID: 8391117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phorbol ester-induced modulation of agonist binding to alpha-1 adrenergic receptors in bovine aortic membranes.
    Jagadeesh G; Deth RC
    J Pharmacol Exp Ther; 1988 Oct; 247(1):196-202. PubMed ID: 2902212
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alpha 2-adrenergic receptor turnover in adipose tissue and kidney: irreversible blockade of alpha 2-adrenergic receptors by benextramine.
    Taouis M; Berlan M; Lafontan M
    Mol Pharmacol; 1987 Jan; 31(1):89-96. PubMed ID: 2880286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interactions of agonists with platelet alpha 2-adrenergic receptors.
    Hoffman BB; Michel T; Brenneman TB; Lefkowitz RJ
    Endocrinology; 1982 Mar; 110(3):926-32. PubMed ID: 6120077
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increase in human platelet alpha 2-adrenergic receptor affinity for agonist in unstable angina.
    Mehta J; Mehta P; Ostrowski N
    J Lab Clin Med; 1985 Dec; 106(6):661-6. PubMed ID: 2866219
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of alpha-2 adrenergic receptors and their regulation in rodent and porcine species.
    Feller DJ; Bylund DB
    J Pharmacol Exp Ther; 1984 Feb; 228(2):275-82. PubMed ID: 6141279
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of alpha-1 adrenergic receptors in the heart using [3H]WB4101: effect of 6-hydroxydopamine treatment.
    Yamada S; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1980 Oct; 215(1):176-85. PubMed ID: 6109014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.